Press Releases

Date	Title	Company
23-Jun-2021	Demy-Colton Announces BioFuture™ Conference to be held at Cure, Deerfield’s Vertical Innovation Campus in New York City	Demy-Colton
23-Jun-2021	HUTCHMED announces savolitinib approved in China for patients with lung cancer with MET exon 14 skipping alterations	HUTCHMED
23-Jun-2021	Genmab Announces that Janssen has Received European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous Formulation, Including for the Treatment of Patients with Newly Diagnosed Light-chain (AL) Amyloidosis	Genmab
23-Jun-2021	LEO Pharma announces MHRA and EC approval of Adtralza▼ (tralokinumab) as the first and only treatment specifically targeting IL-13 only for adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy	LEO Pharma
23-Jun-2021	European Commission Purchases Additional 150 Million Doses of Moderna’s COVID-19 Vaccine for Delivery in 2022	Moderna, Inc.
23-Jun-2021	ProBioGen and LAVA Therapeutics N.V. Sign Agreement for Cell Line Development for Manufacturing of a Novel Bispecific	ProBioGen
23-Jun-2021	Immutep to evaluate efti in triple combination therapy phase I study with chemotherapy and an anti-PD-1 therapy	Immutep Limited
23-Jun-2021	Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting	Santhera Pharmaceuticals
23-Jun-2021	Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)	Nordic Nanovector ASA
23-Jun-2021	EMA validates Algenex’ CrisBio® platform for the manufacturing of vaccines	Algenex SL
23-Jun-2021	ABBOTT EARNS FIRST-OF-ITS-KIND RECOMMENDATION FOR HIGH SCHOOL STEM INTERNS TO RECEIVE COLLEGE CREDIT	ABBOTT
23-Jun-2021	Breakthrough for data sector as Nimble Learn announces launch of analysis-ready Open Data Blend	Nimble Learn
23-Jun-2021	EVERSANA™ expands medical information and integrated compliance services across Europe	EVERSANA™
23-Jun-2021	Algenex and FATRO announce positive CVMP opinion for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease	Algenex SL
23-Jun-2021	Gilead’s Veklury® (Remdesivir) Associated With a Reduction in Mortality Rate in Hospitalized Patients With COVID-19 Across Three Analyses of Large Retrospective Real-World Data Sets	Gilead
23-Jun-2021	Jardiance® (empagliflozin) approved in Europe for the treatment of heart failure with reduced ejection fraction	Boehringer Ingelheim
23-Jun-2021	Orpathys approved in China for patients with lung cancer and MET gene alterations	AstraZeneca
23-Jun-2021	Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas	AstraZeneca
23-Jun-2021	Enara Bio participates in Boehringer Ingelheim’s “Taking Cancer On” podcast series	Enara Bio
23-Jun-2021	CAGR of 23.3% Growth Predicted for Global 4D Printing in Healthcare Market Share to Reach USD 48.95 Billion by 2028	https://wordpress.com/home/uniquemarketideas.wordpress.com